Gerresheimer supplies primary packaging for dexamethasone

Gerresheimer has been commissioned by a customer to produce plastic containers in which the active ingredient dexamethasone is to be filled. According to a study, the active ingredient can reduce the mortality of people who are seriously ill with Covid 19. The medical journal and other media recently reported that the World Health Organization (WHO) had called for an increase in the production of the active ingredient dexamethasone. Headquartered in Düsseldorf in Germany, the manufacturer of primary glass and plastic packaging p roducts for medication and drug delivery kept its customers supplied globally amid the coronavirus crisis. With special products made of glass and plastic, the company contributes to health and well-being. Gerresheimer is represented worldwide, and with around 10,000 employees produce where its customers and markets are and has packaging manufacturing plants in Europe, America and Asia (including India as well). 100ml drug cans with closures “Thanks to globally standardized processes and technologies, we can produce flexibly, locally and sustainably. This also includes optimizing procurement and transport routes for our customers,” says Jens Friis,…

Choose your subscription to read more